Rinvask Contraindications

Pitavastatin is contraindicated in the following conditions: Patients with hypersensitivity to any component of this product. Hypersensitivity reactions such as angioedema, rash, pruritus, and urticaria have been reported with Pitavastatin (see Adverse Reactions).
Patients with liver disease, including unexplained persistent elevations in hepatic transaminases (see Precautions).
Pregnant women or women planning to become pregnant. Pitavastatin inhibits HMG-CoA reductase, reducing cholesterol synthesis and possibly affecting the synthesis of biologically active substances derived from cholesterol, and may cause fetal harm if administered to pregnant women. The safety and efficacy in pregnant women have not been established. If a patient becomes pregnant while taking Pitavastatin, they should be informed of the potential risks to the fetus and the lack of known clinical benefit (see Use in Pregnancy & Lactation).
Nursing mothers. Animal studies have shown that Pitavastatin is excreted into breast milk. As Pitavastatin inhibits HMG-CoA reductase and may cause adverse reactions in nursing infants, it is contraindicated in breastfeeding women (see Use in Pregnancy & Lactation).
Concomitant use with cyclosporine (see Interactions).